Ostro
Ostro is an AI-powered brand engagement platform for life sciences that delivers conversational, MLR-compliant patient and HCP engagement via AI-driven web, email, and telehealth products to top global biopharma companies.
- Company typePrivate
- Founded2019
- HeadquartersMiami, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What Ostro does
Ostro is an AI-powered brand engagement platform purpose-built for the life sciences industry, serving pharmaceutical and biotechnology companies with conversational AI that delivers personalized, compliant interactions for both patients and healthcare professionals. The platform is built around a compliance-by-design architecture in which all AI-generated responses are grounded in each customer's MLR (Medical, Legal, Regulatory)-approved content, marketed as 100% compliant and hallucination-free via semantic search over approved materials. Its product suite comprises Ostro Sites (AI-powered web engagement for patients and HCPs on brand websites), Ostro Email (agent-led, two-way compliant inbox conversations with CRM and next-best-action integration), Ostro Consult (telehealth connecting patients to clinicians), and Ostro Navigate (HCP omnichannel engagement). Underlying AI capabilities include conversational AI, semantic search, generative AI, natural language processing, and recommendation engines layered on top of each customer's proprietary approved content corpus.
Ostro operates a B2B enterprise SaaS model, selling annual subscription contracts to top global biopharma companies through direct enterprise field sales (with "Get a Demo" and "Schedule a Demo" CTAs driving the funnel), and reportedly serves 8 of the top 10 biopharma and most of the top 20 global pharmaceutical companies, including Alexion, Gilead, Johnson & Johnson, BeOne, Ferring, and BridgeBio across 50+ brand deployments. The company was founded in 2019 as RxDefine, rebranded to Ostro in November 2022 alongside a $45 million funding round that brought total funding to over $55 million, and was acquired by Veeva Systems in March 2026 for approximately $100 million in cash and long-term equity retention grants. Following the acquisition, Ostro operates as an independent unit within Veeva's Commercial Cloud suite under continuing CEO Chase Feiger, with planned integrations between Ostro's products and Veeva's enterprise life sciences applications. The company is headquartered in Miami, Florida (incorporated in Delaware as Rise Healthcare Tech, Inc.) and has scaled to 51-100 employees.
Ostro firmographics
Firmographics- Name
- Ostro
- Legal name
- Rise Healthcare Tech, Inc.
- Website
- https://ostrohealth.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Acquired
- Headcount range
- 51–100 employees
- Short description
- Ostro is an AI-powered brand engagement platform for life sciences that delivers conversational, MLR-compliant patient and HCP engagement via AI-driven web, email, and telehealth products to top global biopharma companies.
- Ownership category
- akta.pro rank
Ostro industry classification
Industry- Product category
- Pharmaceutical Marketing & Life Sciences Engagement Software
- NAICS
- Custom Computer Programming Services (541511)
- SIC
- Services-Prepackaged Software (7372), Services-Health Services (8000)
- akta.pro primary industry
- Multi-Condition RPM Platforms & Care Orchestration (device-agnostic, population management) (HLALAFAL)
- akta.pro secondary industries
- Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms (HLALABAK), Virtual Nursing, Telemonitoring & Command Center Platforms (HLACAFAH)
Keywords
Where Ostro is headquartered
LocationHeadquarters
- HQ city
- Miami
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Ostro business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations
Revenue model
- SaaS Platform Licensing: B2B SaaS subscription model providing AI-powered brand engagement platform to life sciences companies. Platform fees likely based on brand engagement volume, number of HCP/patient interactions, and feature tiers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise platform with customizable engagement modules |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Ostro product offering
Product offeringCore offering
Ostro is an AI-powered brand engagement platform for life sciences companies that delivers personalized, MLR-compliant conversational experiences to patients and healthcare professionals (HCPs) across brand websites, email, and telehealth channels. The platform combines conversational AI, semantic search over approved content, and behavioral analytics to help biopharma brands drive high-value actions such as new-to-brand patient enrollment and competitive therapy switching.
Product overview
Ostro is an AI-powered brand engagement platform for life sciences, now part of Veeva Systems following a ~$100M acquisition in March 2026. The platform consists of three core products: Ostro Sites (AI-powered web engagement for patients and HCPs on brand websites), Ostro Email (AI-driven two-way compliant email conversations with HCPs), and Ostro Consult (telehealth integration connecting patients to clinicians). An additional module, Ostro Navigate, extends HCP engagement across omnichannel strategies. The product portfolio delivers personalized 1:1 healthcare journeys, combining conversational AI, semantic search over MLR-approved content, and live Nurse Navigator support to drive treatment confidence, high-value patient actions, and compliant HCP engagement. Formerly known as RxDefine, Ostro rebranded in November 2022 alongside a $45M funding round bringing total funding to over $55M.
Differentiator
Problem solved
Functional benefit
Brands
- Veeva Ostro: The brand engagement platform for life sciences under Veeva, providing AI-powered conversational AI for patients and healthcare professionals.
- Ostro Sites
- Ostro Email
- Ostro Consult
- Ostro Navigate
Products and services
- Ostro Sites
- Ostro Email
- Ostro Consult
- Ostro Navigate
Quantifiable outcome
- 7x lift in specific high-value actions
- +4 more outcomes
Companies that use Ostro
Customer profileNamed customers7 records
Segments3 records
Ideal customer profiles1 record
Ostro technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature6 records
Ostro partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Havas Health NetworkcoreHavas invested in Ostro to enhance its media and creative operations. The investment provides Havas access to Ostro's technology for its global ecosystem and supports clients in the health network. Havas committed nearly €1 billion to Converged.AI strategy including Ostro acquisition.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Ostro competitors and assessment
Company assessmentDirect peers
- Aktana: Aktana is an AI-driven commercial engagement platform for life sciences that coordinates HCP and patient interactions across channels for pharma brands. It directly competes with Ostro's agentic engagement layer and shares the same top-biopharma buyer.
- Swoop: Swoop (formerly Swoop and IPM.ai) provides AI-driven HCP and patient engagement, including conversational and targeted marketing for pharma brands. It is a like-for-like peer competing for the same conversational patient-journey wallet.
- Concentra: Concentra (formerly Concentra Analytics) is a life-sciences commercial analytics and engagement vendor delivering AI-driven HCP and patient activation for pharma brands. Closely comparable to Ostro's brand-engagement value proposition.
- OptimizeRx: OptimizeRx operates a digital health messaging network connecting pharma brands with HCPs and patients at the point-of-prescribe. Comparable to Ostro in targeting biopharma brand teams with AI-enabled HCP/patient engagement.
Emerging players
- PatientPoint: PatientPoint delivers patient and HCP engagement content at the point of care via digital screens, tablets, and print. It overlaps with Ostro in pharma-sponsored patient engagement but operates through a distinct in-office channel.
- Outcome Health: Outcome Health provides health-content engagement at the point of care for pharma and life-sciences sponsors, including patient education and HCP resources. Comparable as a pharma-funded patient engagement platform, though via in-office media rather than web/email.
- Medisafe: Medisafe provides digital medication adherence and patient engagement tools that pharma sponsors offer to patients on therapy. It overlaps with Ostro's patient-journey engagement layer but is focused on adherence rather than conversational brand engagement.
Broad incumbents
- Veeva Systems: Veeva Systems is the parent company of Ostro post-2026 acquisition and the dominant life-sciences CRM/commercial cloud vendor. Its Veeva Commercial Cloud overlaps Ostro's buyer, content, and engagement workflows, making it a broad incumbent peer.
- IQVIA: IQVIA is a global life-sciences services and technology provider whose Orchestrated Customer Engagement (OCE) platform offers AI-driven HCP and patient engagement for pharma. Comparable as a broader-suite incumbent competing for the same commercial-engagement budget.
- Doximity: Doximity is a digital platform for physicians with HCP-targeted engagement products used by pharma for marketing, content, and messaging. Comparable to Ostro's HCP engagement capabilities, though anchored in a physician network rather than brand websites.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
Ostro social profiles
Digital presenceOstro financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ostro leadership team
Management profileNumber of profiles
Profiles6 records
Ostro funding detail
Funding detailFunding overview
Funding rounds6 records
Investors9 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ostro M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ostro
What does Ostro do?
Ostro is an AI-powered brand engagement platform for life sciences companies that delivers personalized, MLR-compliant conversational experiences to patients and healthcare professionals (HCPs) across brand websites, email, and telehealth channels. The platform combines conversational AI, semantic search over approved content, and behavioral analytics to help biopharma brands drive high-value actions such as new-to-brand patient enrollment and competitive therapy switching.
Is Ostro a public or private company?
Ostro is a private company. It is classified as corporate owned and is currently acquired.
When was Ostro founded?
Ostro was founded in 2019. It employs 51 to 100 people.
Where is Ostro based?
Ostro is headquartered in Miami, United States, in the North America region.
How does Ostro make money?
One revenue line is on record: saaS Platform Licensing.
Who are Ostro's main competitors?
Direct peers on record are Aktana, Swoop, Concentra and OptimizeRx. Emerging players are PatientPoint, Outcome Health and Medisafe. Broad incumbents are Veeva Systems, IQVIA and Doximity.
Does Ostro have an API?
No public API is recorded for Ostro.
What industry is Ostro in?
Ostro's product category is Pharmaceutical Marketing & Life Sciences Engagement Software. Its primary akta.pro industry code is HLALAFAL, Multi-Condition RPM Platforms & Care Orchestration (device-agnostic, population management), with a secondary code of HLALABAK, Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms. Its NAICS code is 541511 and its SIC code is 7372.